BRCA2 and breast cancer: The significance of mutation carriers the young age of onset breast cancer has resulted in recommendations from the National Comprehensive Cancer Network® for clinical practice of genetic/familial high risk cases of breast and ovarian cancers to test (concurrent with or following genetic testing of BRCA1 and BRCA2) women with breast cancer diagnoses less than age 35 years of age [9].